| 書目名稱 | Interferon: The Dawn of Recombinant Protein Drugs |
| 編輯 | J. Lindenmann,W.-D. Schleuning |
| 視頻video | http://file.papertrans.cn/471/471000/471000.mp4 |
| 叢書名稱 | Ernst Schering Foundation Symposium Proceedings |
| 圖書封面 |  |
| 描述 | Forty years of Interferon I wish to dedicate this short introduction to the memory of Alick Isaacs (1921-1967), and to that of Sir Christopher Andrewes (1896-1988). Let us go back more than 40 years. In 1956 Isaacs was in charge of the Wodd Influenza Centre. Andrewes was head of the division of bac- teriology and virology, and deputy director of the National Institute for Medical Research in London. When researchers are faced with a seemingly new phenomenon, ex- planations are easy to come by. These explanations fall into two broad categories: the phenomenon in question is either due to something or to the lack of something. I apologize for the primitive way in which I ex- press this, but I am going to give three examples, scattered over 100 years, of what I mean. First example: in 1880 the great French microbiologist Louis Pas- teur was involved in work on chicken cholera. He was struck by the following observation: if a suitable chicken broth was inoculated with the bacterium, the organism grew profusely and the liquid became tur- bid. If he now freed the fluid, by sedimentation or filtration, from the bulk of the organisms and re-inoculated it with the same bacterium, no growth |
| 出版日期 | Conference proceedings 1999 |
| 關(guān)鍵詞 | Multiple Sclerosis; Protein Drugs; cancer; cancer therapy; cytokine; cytokines; interferon; protein; protein |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-662-03787-4 |
| isbn_softcover | 978-3-662-03789-8 |
| isbn_ebook | 978-3-662-03787-4Series ISSN 0947-6075 |
| issn_series | 0947-6075 |
| copyright | Springer-Verlag Berlin Heidelberg 1999 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-24 19:38
發(fā)表于 2025-3-21 18:45:55
